⌘K
Loading ticker…
As of 2026-08-24, DiaMedica Therapeutics Inc. Common Stock (DMAC) has a 3-month relative strength percentile of 68 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 0.58×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
DMAC is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.9% / -9.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
DMAC is held by 8 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $1M.
Held by 13 ETFs · $12M across latest filings · largest weight 0.05% (IWC).
Top 8 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $1M | — |
| VTWG | 0.01% | $193K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $14K | — |
| ITWO | 0.01% | $10K | — |
| URTY | 0.00% | $8K | — |
| UWM | 0.00% | $8K | — |
| HDG | 0.00% | $192 | — |
| RB | 0.00% | $54 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DMAC Jan avg: -2.05% median: 0.15% win: 50% σ: 8.83% n: 4 2022-04-12 → 2026-07-31 | DMAC Feb avg: 11.70% median: 9.88% win: 75% σ: 12.46% n: 4 2022-04-12 → 2026-07-31 | DMAC Mar avg: -19.01% median: -13.20% win: 0% σ: 15.58% n: 4 2022-04-12 → 2026-07-31 | DMAC Apr avg: -0.03% median: 3.11% win: 60% σ: 9.09% n: 5 2022-04-12 → 2026-07-31 | DMAC May avg: 16.98% median: 4.74% win: 60% σ: 28.94% n: 5 2022-04-12 → 2026-07-31 | DMAC Jun avg: 11.10% median: 1.72% win: 60% σ: 29.14% n: 5 2022-04-12 → 2026-07-31 | DMAC Jul avg: -6.13% median: -9.94% win: 40% σ: 15.10% n: 5 2022-04-12 → 2026-07-31 | DMAC Aug avg: 12.42% median: 13.54% win: 75% σ: 20.31% n: 4 2022-04-12 → 2026-07-31 (current) | DMAC Sep avg: -3.89% median: -2.96% win: 50% σ: 21.98% n: 4 2022-04-12 → 2026-07-31 | DMAC Oct avg: -3.32% median: -1.04% win: 50% σ: 9.05% n: 4 2022-04-12 → 2026-07-31 | DMAC Nov avg: 16.10% median: 17.08% win: 100% σ: 12.45% n: 4 2022-04-12 → 2026-07-31 | DMAC Dec avg: 9.36% median: 6.21% win: 50% σ: 18.88% n: 4 2022-04-12 → 2026-07-31 |